(Mayo Clinic) Researchers at the Mayo Clinic campus in Florida have found that PKC-iota (PKC-i), an oncogene important in colon and lung cancers, is over-produced in pancreatic cancer and is linked to poor patient survival. They also found that genetically inhibiting PKC-i in laboratory animals led to a significant decrease in pancreatic tumor growth and spread.

Further information:

Article source

Related posts:

1. Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice
2. MRI Finds Tumors in Second Breast of Women Diagnosed with Cancer in One Breast, Mayo Clinic Researchers Say
3. Mayo Clinic Announces Five March Performancesfor the Rosemary and Meredith Willson Harmonyfor Mayo Program
4. Mayo Clinic introduces 2 consumer mobile applications
5. Mayo Clinic, HealthForce Minnesota Bring Mobile Science Lab to Area Students